Literature DB >> 23328778

[Elderly prostate cancer patients: patient information and shared decision making].

N Ernstmann1, J Jaeger, C Kowalski, H Pfaff, L Weißbach.   

Abstract

INTRODUCTION: Some data exist on information and decision-making preferences of elderly prostate cancer patients but little is known about whether communication needs are being met in urological practice. Therefore, it was the aim of this study to examine the information and shared decision-making experiences of prostate cancer patients over 75 years old.
MATERIALS AND METHODS: The HAROW (hormonal therapy, active surveillance, radiation, operation and watchful waiting) study is a prospective, observational study designed to collect clinical data and patient reported outcome of different treatment options for patients newly diagnosed with localized prostate cancer under real conditions. At 6-month intervals general clinical data, PROs (e.g. quality of life, quality of physician-patient interaction) and individual costs are documented. Data from 2,482 patients at 4 time points from T0 (initial diagnosis) to T3 (24 months follow-up) were analyzed.
RESULTS: T-tests and χ(2)-tests revealed no significant differences in terms of shared decision-making and information to different treatment options between patients aged over 75 years old and the rest of the sample. Regarding information on self-help groups, rehabilitation options and a second medical opinion, there were significant differences between prostate cancer patient age groups: patients aged over 75 years old received less information on these aspects at all points in time.
CONCLUSION: Patients at all ages feel activated by urologists and are informed about different treatment options. However, there is room for improvement in terms of informing especially elderly prostate cancer patients about rehabilitation, second medical opinions and self-help groups. Special information tools and decision aids for prostate cancer patients aged over 75 years old should be developed and implemented to meet the specific information needs.

Entities:  

Mesh:

Year:  2013        PMID: 23328778     DOI: 10.1007/s00120-012-3071-7

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  23 in total

1.  What questions do patients with curable prostate cancer want answered?

Authors:  D Feldman-Stewart; M D Brundage; C Hayter; P Groome; J C Nickel; H Downes; W J Mackillop
Journal:  Med Decis Making       Date:  2000 Jan-Mar       Impact factor: 2.583

2.  Treating older men with prostate cancer: survival (or selection) of the fittest?

Authors:  Mark S Litwin; David C Miller
Journal:  JAMA       Date:  2006-12-13       Impact factor: 56.272

3.  Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study.

Authors:  L C Harlan; A Potosky; F D Gilliland; R Hoffman; P C Albertsen; A S Hamilton; J W Eley; J L Stanford; R A Stephenson
Journal:  J Natl Cancer Inst       Date:  2001-12-19       Impact factor: 13.506

4.  Treatment decision-making strategies and influences in patients with localized prostate carcinoma.

Authors:  Clement K Gwede; Julio Pow-Sang; John Seigne; Randy Heysek; Mohamed Helal; Kristin Shade; Alan Cantor; Paul B Jacobsen
Journal:  Cancer       Date:  2005-10-01       Impact factor: 6.860

5.  What prostate cancer patients should know: variation in professionals' opinions.

Authors:  D Feldman-Stewart; M D Brundage; C Hayter; P Groome; J C Nickel; H Downes; W J Mackillop
Journal:  Radiother Oncol       Date:  1998-11       Impact factor: 6.280

6.  [Urinary incontinence after radical prostatectomy: do older patients have an increased risk?].

Authors:  H Borrusch; G Müller; U Otto
Journal:  Urologe A       Date:  2011-04       Impact factor: 0.639

7.  [Diagnosis prostate cancer: who makes the treatment decision and which treatment is selected? Opinion survey in a prostate cancer patient support group].

Authors:  D Schnell; H Fiebrandt; L Weissbach
Journal:  Urologe A       Date:  2012-02       Impact factor: 0.639

8.  Do patients with localized prostate cancer treatment really want more aggressive treatment?

Authors:  Julia J van Tol-Geerdink; Peep F M Stalmeier; Emile N J T van Lin; Eric C Schimmel; Henk Huizenga; Wim A J van Daal; Jan-Willem Leer
Journal:  J Clin Oncol       Date:  2006-10-01       Impact factor: 44.544

9.  Why patients choose prostatectomy or brachytherapy for localized prostate cancer: results of a descriptive survey.

Authors:  Joshua D Hall; James C Boyd; Marguerite C Lippert; Dan Theodorescu
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

10.  Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.

Authors:  B Joyce Davison; S Larry Goldenberg; Martin E Gleave; Lesley F Degner
Journal:  Oncol Nurs Forum       Date:  2003 Jan-Feb       Impact factor: 2.172

View more
  6 in total

1.  [Oncological healthcare research in urology - perspectives].

Authors:  J Bruns; C Kowalski
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

2.  [Shared decision-making in prostate cancer patients].

Authors:  S Gröger; C Mäder-Porombka; C Stang; S Wallacher
Journal:  Urologe A       Date:  2019-11       Impact factor: 0.639

3.  Prostate cancer navigation: initial experience and association with time to care.

Authors:  Emily C Serrell; Moritz Hansen; Greg Mills; Andrew Perry; Tracy Robbins; Melanie Feinberg; Scot C Remick; Lisa Beaule; Matt Hayn; Tom Kinkead; Paul K J Han; Jesse D Sammon
Journal:  World J Urol       Date:  2018-08-27       Impact factor: 4.226

4.  [The HAROW study: an example of outcomes research: a prospective, non-interventional study comparing treatment options in localized prostate cancer].

Authors:  J Herden; N Ernstmann; D Schnell; L Weißbach
Journal:  Urologe A       Date:  2014-12       Impact factor: 0.639

5.  [Health services research in psycho-oncology].

Authors:  A Mehnert; T J Hartung
Journal:  Nervenarzt       Date:  2015-03       Impact factor: 1.214

Review 6.  Locally advanced prostate cancer: optimal therapy in older patients.

Authors:  Michael Froehner; Manfred P Wirth
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.